カテゴリー： 世界, Technavio

医療用食品の世界市場2024-2028

【英語タイトル】Medical Foods Market Analysis, Size, and Forecast 2024-2028

Technavioが出版した調査資料（IRTNTR71294）・商品コード：IRTNTR71294
・発行会社（調査会社）：Technavio
・発行日：2024年10月
・ページ数：130
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：食品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥375,000見積依頼/購入/質問フォーム
Enterprise User（法人閲覧用）USD5,000 ⇒換算￥750,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界のメディカルフーズ（医療用食品）市場は、2023～2028年に年平均4.8％で成長し、期間中に約51億9,000万米ドル拡大すると予測されている。高齢化の進展と、糖尿病や栄養失調など慢性疾患の増加が主な成長要因であり、高齢者の特有な栄養ニーズを満たす製品開発が市場拡大の中心となっている。一方で、メディカルフーズの定義や規制が国・地域によって異なるため、市場参入や製品開発を複雑にしており、標準化の欠如が業界の課題となっている。企業は各国の法規制を深く理解し、行政機関との協調を図りながら、疾患別・症状別に特化した製品を開発することが求められている。

製品形態では、粉末タイプが最大のシェアを占め、腎疾患、肝性脳症、がん治療後の下痢、糖尿病性神経障害、ADHD、うつ病、アルツハイマー病、代謝異常症など、多様な疾患に対応した処方が行われている。これらは栄養不足を補い、オメガ3脂肪酸や食物繊維の補給、腸内環境の改善、免疫機能の強化などを目的としており、厳格な品質管理と法規制順守のもとで製造される。カロリー密度、ミネラルバランス、吸収効率、保存安定性も重視され、臨床栄養・経腸栄養向けの処方開発が進む。

地域別ではアジア太平洋地域（APAC）が世界市場成長の約38％を占める見込みで、中国・インド・日本などで高齢化と生活習慣病の増加が需要を支えている。北米では肥満や糖尿病の増加により、栄養補助食品や処方栄養食の消費が拡大。米国疾病予防管理センター（CDC）によると、2023年時点で米国人口の約8.9％が糖尿病を抱えており、栄養バランスの改善と病態管理を目的にメディカルフーズの利用が進む。

市場動向としては、慢性疾患や高齢者の栄養管理への関心の高まりにより、病態別栄養管理（特に代謝性疾患・消化器疾患・糖尿病）に特化した製品開発が拡大している。家庭での経腸栄養（HEN）やオンライン販売の普及も市場拡大を後押ししている。一方、国際的な規制の不統一が市場成長を抑制しており、米国ではFDAが1988年孤児薬法改正に基づき「医療用食品」を定義しているが、欧州や新興国では制度整備が途上である。

主要企業は、アボット（Ensure, EleCareなど）、ネスレ、ダノン、フレゼニウス・カービ、明治ホールディングス、アルファシグマなど。各社は糖尿病、がん、代謝疾患向けの新製品投入や大学・研究機関との提携を通じて市場を拡大している。2024年にはネスレが消化器疾患向け「Peptamen 1.5」を発売、アボットは糖尿病患者向け「Glucerna RFA」でFDA承認を取得、フレゼニウス・カービは米UCSFと希少代謝疾患向け食品の共同開発を発表した。

総じて、メディカルフーズ市場は「高齢化」「慢性疾患」「栄養科学の進化」を背景に持続的成長が見込まれる。疾患別の栄養療法や個別化栄養（パーソナライズド・ニュートリション）の進展により、今後も医療・栄養分野の重要な成長領域として拡大が続くと見られている。

The medical foods market size is forecast to increase by USD 5.19 billion, at a CAGR of 4.8% between 2023 and 2028.
• The market is experiencing significant growth, driven by the increasing geriatric population and rising prevalence of conditions such as malnutrition and diabetes. The elderly demographic, with their unique nutritional needs, presents a substantial market opportunity for medical food manufacturers. Additionally, the growing number of individuals diagnosed with chronic conditions necessitates specialized nutritional solutions, further fueling market expansion. However, the market faces challenges in the form of discrepancies in the categorization of medical foods. The lack of a standardized definition and regulatory framework complicates market entry and product development for companies.
• Navigating these complexities requires a deep understanding of the regulatory landscape and strategic partnerships with regulatory bodies. To capitalize on market opportunities and effectively address challenges, companies must remain agile and innovative, focusing on developing targeted, evidence-based medical food solutions for specific conditions.

The market continues to evolve, driven by the increasing demand for specialized nutritional solutions across various sectors. Infant nutrition remains a significant focus, with ongoing research and development in ingredient sourcing to ensure optimal nutrition for growing infants. Specialized diets, including those for toddlers, patients with food allergies, and those requiring metabolic support, are also gaining traction. Patient compliance is a critical factor in the success of medical food products, with a focus on extended shelf life and convenient packaging requirements. Elderly nutrition and hepatic support are emerging areas of interest, as the global population ages and nutritional needs shift.
Regulatory compliance, including protein supplementation and vitamin fortification, plays a crucial role in the development of medical foods. The importance of nutrient absorption, calorie density, mineral balance, and weight management is also a key consideration. Formula development for enteral nutrition and clinical nutrition continues to advance, with a focus on disease management, glucose control, appetite stimulation, and renal support. The gut microbiome and immune function are also areas of increasing interest, with omega-3 fatty acids and dietary fiber playing essential roles. The market is characterized by continuous innovation, with ongoing research and development in nutritional deficiencies, nutrient absorption, and regulatory compliance.
The market’s dynamism is reflected in the evolving patterns of ingredient sourcing, product formulation, and quality control.

The medical foods industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in “USD million” for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
• Product
o Powder
o Pill
o Others
• Type
o Oral Nutrition
o Enteral Nutrition
o Metabolic Disorder Formulas
• Application
o Diabetes
o Cancer
o Neurological Disorders
o Inborn Errors of Metabolism
• Distribution Channel
o Pharmacies
o Hospitals & Clinics
o Online Retail
o Specialty Stores
• Geography
o North America
 US
 Canada
o Europe
 France
 Germany
 Italy
 UK
o Middle East and Africa
 Egypt
 KSA
 Oman
 UAE
o APAC
 China
 India
 Japan
o South America
 Argentina
 Brazil
o Rest of World (ROW)

By Product Insights
The powder segment is estimated to witness significant growth during the forecast period.
In the market, companies provide powder medical foods tailored to address the unique nutritional requirements of diverse patient populations. Developed through collaborative efforts between registered dieticians, food scientists, and nutritionists, these powders cater to adults, geriatric consumers, infants, children, and new mothers. They support disease management for conditions such as chronic kidney disease, minimal hepatic encephalopathy, chemotherapy-induced diarrhea, pathogen-related infections, diabetic neuropathy, attention deficit hyperactivity disorder (ADHD), depression, Alzheimer’s disease, nutritional deficiencies, and various orphan diseases like phenylketonuria and eosinophilic esophagitis. These medical foods are formulated to meet specific dietary needs, including specialized diets for food allergies, gut microbiome management, and metabolic support.
They offer enteral nutrition, hepatic support, and omega-3 fatty acid supplementation. companies prioritize regulatory compliance, ensuring product formulation aligns with medical food regulations. Quality control and packaging requirements are stringently adhered to, while vitamin fortification enhances nutrient absorption. Calorie density and mineral balance are crucial considerations, with some products designed for weight management and renal support. Glucose control and appetite stimulation are essential features for certain patient populations. Dietary fiber and clinical nutrition support digestive health and immune function. companies prioritize shelf life, ensuring patients receive effective and safe medical foods.

APAC is estimated to contribute 38% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

In North America, there is a significant increase in the consumption of medical foods, dietary supplements, and prescription drugs due to the rising prevalence of obesity and chronic diseases, including cardiovascular conditions. This trend is driven by the deficiency of essential nutrients in diets and the inclusion of synthetic products. According to the Centers for Disease Control and Prevention (CDC), in 2023, approximately 8.9% of the US population had diabetes, with this number growing by 5% annually. Medical foods play a crucial role in addressing nutritional deficiencies and supporting various health conditions, such as metabolic disorders, enteral feeding, hepatic support, and immune function.
These foods cater to specialized diets, including infant and toddler nutrition, and address food allergies and gut microbiome imbalances. Regulatory compliance is essential in the production of medical foods, ensuring quality control, vitamin fortification, and mineral balance. Shelf life, calorie density, and appetite stimulation are also critical factors in their formulation. Renal support, clinical nutrition, and digestive health are other areas where medical foods offer significant benefits. In the development of medical foods, ingredient sourcing, product formulation, and regulatory compliance are key considerations. Packaging requirements and nutrient absorption are also essential aspects of medical food production. Omega-3 fatty acids, protein supplementation, and disease management are some of the other areas where medical foods provide essential support.
Market Dynamics
The Global Medical Foods Market is experiencing significant medical foods market growth, largely due to the increasing focus on dietary management of disease and the rising prevalence of medical foods for chronic diseases. A growing aging population (medical foods) further fuels demand for specialized nutritional support. Products like medical food powders and liquid medical foods are crucial for malnutrition (medical foods) prevention and treatment, often used in clinical nutrition settings and for hospital nutrition. The Global medical foods market size continues to expand, driven by robust new product development medical foods and evolving medical foods industry trends. Specialized formulas, such as medical foods for metabolic disorders and medical foods for gastrointestinal disorders, are vital for specific patient groups. The convenience of e-commerce medical foods is enhancing accessibility, offering nutritionally complete medical foods for home use through programs like home enteral nutrition (HEN). The future of this market is also being shaped by personalized nutrition and the complex regulatory landscape medical foods.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, medical foods market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories – This company specializes in the provision of a comprehensive selection of medical food brands, including Elecare and Ensure, catering to various nutritional needs.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
• Abbott Laboratories
• Alfasigma Spa
• Bausch Health Companies Inc.
• Danone SA
• Entera Health Inc.
• Fresenius Kabi AG
• Medtrition Inc.
• Meiji Holdings Co. Ltd.
• Metagenics LLC
• Nestle SA
• Physician Therapeutics LLC
• Primus Pharmaceuticals Inc.
• Proliant Inc.
• Reckitt Benckiser Group Plc
• Targeted Medical Pharma Inc.
• Upsher Smith Laboratories LLC
• Victus Inc.

❖ レポートの目次 ❖

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary – Chart on Market Overview
    • Executive Summary – Data Table on Market Overview
    • Executive Summary – Chart on Global Market Characteristics
    • Executive Summary – Chart on Market by Geography
    • Executive Summary – Chart on Market Segmentation by Product
    • Executive Summary – Chart on Incremental Growth
    • Executive Summary – Data Table on Incremental Growth
    • Executive Summary – Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on – Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global – Market size and forecast 2023-2028 ($ million)
    • Data Table on Global – Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Medical Foods Market 2018 – 2022
    • Historic Market Size – Data Table on Global Medical Foods Market 2018 – 2022 ($ million)
  • 4.2 Product segment analysis 2018 – 2022
    • Historic Market Size – Product Segment 2018 – 2022 ($ million)
  • 4.3 Geography segment analysis 2018 – 2022
    • Historic Market Size – Geography Segment 2018 – 2022 ($ million)
  • 4.4 Country segment analysis 2018 – 2022
    • Historic Market Size – Country Segment 2018 – 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis – Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers – Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers – Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants – Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes – Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry – Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition – Five forces 2023 and 2028

6 Market Segmentation by Product

  • 6.1 Market segments
    • Chart on Product – Market share (2023-2028) (%)
    • Data Table on Product – Market share (2023-2028) (%)
  • 6.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 6.3 Powder – Market size and forecast (2023-2028)
    • Chart on Powder – Market size and forecast (2023-2028) ($ million)
    • Data Table on Powder – Market size and forecast (2023-2028) ($ million)
    • Chart on Powder – Year-over-year growth (2023-2028) (%)
    • Data Table on Powder – Year-over-year growth (2023-2028) (%)
  • 6.4 Pill – Market size and forecast (2023-2028)
    • Chart on Pill – Market size and forecast (2023-2028) ($ million)
    • Data Table on Pill – Market size and forecast (2023-2028) ($ million)
    • Chart on Pill – Year-over-year growth (2023-2028) (%)
    • Data Table on Pill – Year-over-year growth (2023-2028) (%)
  • 6.5 Others – Market size and forecast (2023-2028)
    • Chart on Others – Market size and forecast (2023-2028) ($ million)
    • Data Table on Others – Market size and forecast (2023-2028) ($ million)
    • Chart on Others – Year-over-year growth (2023-2028) (%)
    • Data Table on Others – Year-over-year growth (2023-2028) (%)
  • 6.6 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
    • Chart on Type – Market share (2023-2028) (%)
    • Data Table on Type – Market share (2023-2028) (%)
  • 7.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 7.3 Oral Nutrition – Market size and forecast (2023-2028)
    • Chart on Oral Nutrition – Market size and forecast (2023-2028) ($ million)
    • Data Table on Oral Nutrition – Market size and forecast (2023-2028) ($ million)
    • Chart on Oral Nutrition – Year-over-year growth (2023-2028) (%)
    • Data Table on Oral Nutrition – Year-over-year growth (2023-2028) (%)
  • 7.4 Enteral Nutrition – Market size and forecast (2023-2028)
    • Chart on Enteral Nutrition – Market size and forecast (2023-2028) ($ million)
    • Data Table on Enteral Nutrition – Market size and forecast (2023-2028) ($ million)
    • Chart on Enteral Nutrition – Year-over-year growth (2023-2028) (%)
    • Data Table on Enteral Nutrition – Year-over-year growth (2023-2028) (%)
  • 7.5 Metabolic Disorder Formulas – Market size and forecast (2023-2028)
    • Chart on Metabolic Disorder Formulas – Market size and forecast (2023-2028) ($ million)
    • Data Table on Metabolic Disorder Formulas – Market size and forecast (2023-2028) ($ million)
    • Chart on Metabolic Disorder Formulas – Year-over-year growth (2023-2028) (%)
    • Data Table on Metabolic Disorder Formulas – Year-over-year growth (2023-2028) (%)
  • 7.6 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

8 Market Segmentation by Application

  • 8.1 Market segments
    • Chart on Application – Market share (2023-2028) (%)
    • Data Table on Application – Market share (2023-2028) (%)
  • 8.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 8.3 Diabetes – Market size and forecast (2023-2028)
    • Chart on Diabetes – Market size and forecast (2023-2028) ($ million)
    • Data Table on Diabetes – Market size and forecast (2023-2028) ($ million)
    • Chart on Diabetes – Year-over-year growth (2023-2028) (%)
    • Data Table on Diabetes – Year-over-year growth (2023-2028) (%)
  • 8.4 Cancer – Market size and forecast (2023-2028)
    • Chart on Cancer – Market size and forecast (2023-2028) ($ million)
    • Data Table on Cancer – Market size and forecast (2023-2028) ($ million)
    • Chart on Cancer – Year-over-year growth (2023-2028) (%)
    • Data Table on Cancer – Year-over-year growth (2023-2028) (%)
  • 8.5 Neurological Disorders – Market size and forecast (2023-2028)
    • Chart on Neurological Disorders – Market size and forecast (2023-2028) ($ million)
    • Data Table on Neurological Disorders – Market size and forecast (2023-2028) ($ million)
    • Chart on Neurological Disorders – Year-over-year growth (2023-2028) (%)
    • Data Table on Neurological Disorders – Year-over-year growth (2023-2028) (%)
  • 8.6 Inborn Errors of Metabolism – Market size and forecast (2023-2028)
    • Chart on Inborn Errors of Metabolism – Market size and forecast (2023-2028) ($ million)
    • Data Table on Inborn Errors of Metabolism – Market size and forecast (2023-2028) ($ million)
    • Chart on Inborn Errors of Metabolism – Year-over-year growth (2023-2028) (%)
    • Data Table on Inborn Errors of Metabolism – Year-over-year growth (2023-2028) (%)
  • 8.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Distribution Channel

  • 9.1 Market segments
    • Chart on Distribution Channel – Market share (2023-2028) (%)
    • Data Table on Distribution Channel – Market share (2023-2028) (%)
  • 9.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 9.3 Pharmacies – Market size and forecast (2023-2028)
    • Chart on Pharmacies – Market size and forecast (2023-2028) ($ million)
    • Data Table on Pharmacies – Market size and forecast (2023-2028) ($ million)
    • Chart on Pharmacies – Year-over-year growth (2023-2028) (%)
    • Data Table on Pharmacies – Year-over-year growth (2023-2028) (%)
  • 9.4 Hospitals & Clinics – Market size and forecast (2023-2028)
    • Chart on Hospitals & Clinics – Market size and forecast (2023-2028) ($ million)
    • Data Table on Hospitals & Clinics – Market size and forecast (2023-2028) ($ million)
    • Chart on Hospitals & Clinics – Year-over-year growth (2023-2028) (%)
    • Data Table on Hospitals & Clinics – Year-over-year growth (2023-2028) (%)
  • 9.5 Online Retail – Market size and forecast (2023-2028)
    • Chart on Online Retail – Market size and forecast (2023-2028) ($ million)
    • Data Table on Online Retail – Market size and forecast (2023-2028) ($ million)
    • Chart on Online Retail – Year-over-year growth (2023-2028) (%)
    • Data Table on Online Retail – Year-over-year growth (2023-2028) (%)
  • 9.6 Specialty Stores – Market size and forecast (2023-2028)
    • Chart on Specialty Stores – Market size and forecast (2023-2028) ($ million)
    • Data Table on Specialty Stores – Market size and forecast (2023-2028) ($ million)
    • Chart on Specialty Stores – Year-over-year growth (2023-2028) (%)
    • Data Table on Specialty Stores – Year-over-year growth (2023-2028) (%)
  • 9.7 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share by geography 2023-2028 (%)
    • Data Table on Market share by geography 2023-2028 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America – Market size and forecast 2023-2028
    • Chart on North America – Market size and forecast 2023-2028 ($ million)
    • Data Table on North America – Market size and forecast 2023-2028 ($ million)
    • Chart on North America – Year-over-year growth 2023-2028 (%)
    • Data Table on North America – Year-over-year growth 2023-2028 (%)
  • 11.4 Europe – Market size and forecast 2023-2028
    • Chart on Europe – Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe – Market size and forecast 2023-2028 ($ million)
    • Chart on Europe – Year-over-year growth 2023-2028 (%)
    • Data Table on Europe – Year-over-year growth 2023-2028 (%)
  • 11.5 APAC – Market size and forecast 2023-2028
    • Chart on APAC – Market size and forecast 2023-2028 ($ million)
    • Data Table on APAC – Market size and forecast 2023-2028 ($ million)
    • Chart on APAC – Year-over-year growth 2023-2028 (%)
    • Data Table on APAC – Year-over-year growth 2023-2028 (%)
  • 11.6 South America – Market size and forecast 2023-2028
    • Chart on South America – Market size and forecast 2023-2028 ($ million)
    • Data Table on South America – Market size and forecast 2023-2028 ($ million)
    • Chart on South America – Year-over-year growth 2023-2028 (%)
    • Data Table on South America – Year-over-year growth 2023-2028 (%)
  • 11.7 Middle East and Africa – Market size and forecast 2023-2028
    • Chart on Middle East and Africa – Market size and forecast 2023-2028 ($ million)
    • Data Table on Middle East and Africa – Market size and forecast 2023-2028 ($ million)
    • Chart on Middle East and Africa – Year-over-year growth 2023-2028 (%)
    • Data Table on Middle East and Africa – Year-over-year growth 2023-2028 (%)
  • 11.8 US – Market size and forecast 2023-2028
    • Chart on US – Market size and forecast 2023-2028 ($ million)
    • Data Table on US – Market size and forecast 2023-2028 ($ million)
    • Chart on US – Year-over-year growth 2023-2028 (%)
    • Data Table on US – Year-over-year growth 2023-2028 (%)
  • 11.9 China – Market size and forecast 2023-2028
    • Chart on China – Market size and forecast 2023-2028 ($ million)
    • Data Table on China – Market size and forecast 2023-2028 ($ million)
    • Chart on China – Year-over-year growth 2023-2028 (%)
    • Data Table on China – Year-over-year growth 2023-2028 (%)
  • 11.10 Germany – Market size and forecast 2023-2028
    • Chart on Germany – Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany – Market size and forecast 2023-2028 ($ million)
    • Chart on Germany – Year-over-year growth 2023-2028 (%)
    • Data Table on Germany – Year-over-year growth 2023-2028 (%)
  • 11.11 France – Market size and forecast 2023-2028
    • Chart on France – Market size and forecast 2023-2028 ($ million)
    • Data Table on France – Market size and forecast 2023-2028 ($ million)
    • Chart on France – Year-over-year growth 2023-2028 (%)
    • Data Table on France – Year-over-year growth 2023-2028 (%)
  • 11.12 UK – Market size and forecast 2023-2028
    • Chart on UK – Market size and forecast 2023-2028 ($ million)
    • Data Table on UK – Market size and forecast 2023-2028 ($ million)
    • Chart on UK – Year-over-year growth 2023-2028 (%)
    • Data Table on UK – Year-over-year growth 2023-2028 (%)
  • 11.13 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)
  • 11.14 US – Market size and forecast (2023-2028)
    • Chart on US – Market size and forecast (2023-2028) ($ million)
    • Data Table on US – Market size and forecast (2023-2028) ($ million)
    • Chart on US – Year-over-year growth (2023-2028) (%)
    • Data Table on US – Year-over-year growth (2023-2028) (%)
  • 11.15 Canada – Market size and forecast (2023-2028)
    • Chart on Canada – Market size and forecast (2023-2028) ($ million)
    • Data Table on Canada – Market size and forecast (2023-2028) ($ million)
    • Chart on Canada – Year-over-year growth (2023-2028) (%)
    • Data Table on Canada – Year-over-year growth (2023-2028) (%)
  • 11.16 Italy – Market size and forecast (2023-2028)
    • Chart on Italy – Market size and forecast (2023-2028) ($ million)
    • Data Table on Italy – Market size and forecast (2023-2028) ($ million)
    • Chart on Italy – Year-over-year growth (2023-2028) (%)
    • Data Table on Italy – Year-over-year growth (2023-2028) (%)
  • 11.17 India – Market size and forecast (2023-2028)
    • Chart on India – Market size and forecast (2023-2028) ($ million)
    • Data Table on India – Market size and forecast (2023-2028) ($ million)
    • Chart on India – Year-over-year growth (2023-2028) (%)
    • Data Table on India – Year-over-year growth (2023-2028) (%)
  • 11.18 Japan – Market size and forecast (2023-2028)
    • Chart on Japan – Market size and forecast (2023-2028) ($ million)
    • Data Table on Japan – Market size and forecast (2023-2028) ($ million)
    • Chart on Japan – Year-over-year growth (2023-2028) (%)
    • Data Table on Japan – Year-over-year growth (2023-2028) (%)
  • 11.19 Brazil – Market size and forecast (2023-2028)
    • Chart on Brazil – Market size and forecast (2023-2028) ($ million)
    • Data Table on Brazil – Market size and forecast (2023-2028) ($ million)
    • Chart on Brazil – Year-over-year growth (2023-2028) (%)
    • Data Table on Brazil – Year-over-year growth (2023-2028) (%)
  • 11.20 Egypt – Market size and forecast (2023-2028)
    • Chart on Egypt – Market size and forecast (2023-2028) ($ million)
    • Data Table on Egypt – Market size and forecast (2023-2028) ($ million)
    • Chart on Egypt – Year-over-year growth (2023-2028) (%)
    • Data Table on Egypt – Year-over-year growth (2023-2028) (%)
  • 11.21 UAE – Market size and forecast (2023-2028)
    • Chart on UAE – Market size and forecast (2023-2028) ($ million)
    • Data Table on UAE – Market size and forecast (2023-2028) ($ million)
    • Chart on UAE – Year-over-year growth (2023-2028) (%)
    • Data Table on UAE – Year-over-year growth (2023-2028) (%)
  • 11.22 Oman – Market size and forecast (2023-2028)
    • Chart on Oman – Market size and forecast (2023-2028) ($ million)
    • Data Table on Oman – Market size and forecast (2023-2028) ($ million)
    • Chart on Oman – Year-over-year growth (2023-2028) (%)
    • Data Table on Oman – Year-over-year growth (2023-2028) (%)
  • 11.23 Argentina – Market size and forecast (2023-2028)
    • Chart on Argentina – Market size and forecast (2023-2028) ($ million)
    • Data Table on Argentina – Market size and forecast (2023-2028) ($ million)
    • Chart on Argentina – Year-over-year growth (2023-2028) (%)
    • Data Table on Argentina – Year-over-year growth (2023-2028) (%)
  • 11.24 KSA – Market size and forecast (2023-2028)
    • Chart on KSA – Market size and forecast (2023-2028) ($ million)
    • Data Table on KSA – Market size and forecast (2023-2028) ($ million)
    • Chart on KSA – Year-over-year growth (2023-2028) (%)
    • Data Table on KSA – Year-over-year growth (2023-2028) (%)
  • 11.25 Rest of World (ROW) – Market size and forecast (2023-2028)
    • Chart on Rest of World (ROW) – Market size and forecast (2023-2028) ($ million)
    • Data Table on Rest of World (ROW) – Market size and forecast (2023-2028) ($ million)
    • Chart on Rest of World (ROW) – Year-over-year growth (2023-2028) (%)
    • Data Table on Rest of World (ROW) – Year-over-year growth (2023-2028) (%)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Market positioning of companies
    • Matrix on companies position and classification
  • 14.3 Abbott Laboratories
    • Abbott Laboratories – Overview
    • Abbott Laboratories – Business segments
    • Abbott Laboratories – Key news
    • Abbott Laboratories – Key offerings
    • Abbott Laboratories – Segment focus
  • 14.4 Danone SA
    • Danone SA – Overview
    • Danone SA – Business segments
    • Danone SA – Key news
    • Danone SA – Key offerings
    • Danone SA – Segment focus
  • 14.5 Fresenius Kabi AG
    • Fresenius Kabi AG – Overview
    • Fresenius Kabi AG – Product / Service
    • Fresenius Kabi AG – Key offerings
  • 14.6 Medtrition Inc.
    • Medtrition Inc. – Overview
    • Medtrition Inc. – Product / Service
    • Medtrition Inc. – Key offerings
  • 14.7 Metagenics LLC
    • Metagenics LLC – Overview
    • Metagenics LLC – Product / Service
    • Metagenics LLC – Key offerings
  • 14.8 Nestle SA
    • Nestle SA – Overview
    • Nestle SA – Business segments
    • Nestle SA – Key news
    • Nestle SA – Key offerings
    • Nestle SA – Segment focus
  • 14.9 Primus Pharmaceuticals Inc.
    • Primus Pharmaceuticals Inc. – Overview
    • Primus Pharmaceuticals Inc. – Product / Service
    • Primus Pharmaceuticals Inc. – Key offerings
  • 14.10 Proliant Inc.
    • Proliant Inc. – Overview
    • Proliant Inc. – Product / Service
    • Proliant Inc. – Key offerings
  • 14.11 Reckitt Benckiser Group Plc
    • Reckitt Benckiser Group Plc – Overview
    • Reckitt Benckiser Group Plc – Business segments
    • Reckitt Benckiser Group Plc – Key news
    • Reckitt Benckiser Group Plc – Key offerings
    • Reckitt Benckiser Group Plc – Segment focus
  • 14.12 Targeted Medical Pharma Inc.
    • Targeted Medical Pharma Inc. – Overview
    • Targeted Medical Pharma Inc. – Product / Service
    • Targeted Medical Pharma Inc. – Key offerings

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations


★調査レポート[医療用食品の世界市場2024-2028] (コード：IRTNTR71294)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用食品の世界市場2024-2028]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • Global Digital Therapeutics Market 2024-2028
  • 世界・日本のタキシフォリン市場2022-2028
  • 世界及び日本のリトレッドタイヤ市場2022-2028
  • 世界及び日本のSDメモリーカード市場2022-2028
  • 世界・日本のランセット市場2022-2028
  • インダクタの世界市場予測2022-2028
  • 炭素繊維製自転車フレームの世界市場2017-2028
  • 世界の杭打ち機市場2022：企業別・地域別・種類別・用途別市場予測（~2028）
  • スフィンゴ脂質の世界市場2022-2028
  • 電磁接触器の世界市場2022-2028

    • ◆H&Iグローバルリサーチのお客様（例）◆